101 |
Fresenius Kabi USA, LLC v. Mylan Laboratories Limited et al |
1:14-cv-00205 |
N.D.W.Va. |
|
|
|
|
102 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
103 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
104 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
105 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
106 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
107 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
108 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
109 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
110 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
111 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
112 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
113 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
114 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
115 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
116 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
117 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
118 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
119 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
120 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
121 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
122 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
123 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
124 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
125 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
126 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
127 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
128 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
129 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
130 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
131 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
132 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
133 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
134 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
135 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
136 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
137 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
138 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
139 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
140 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
141 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
142 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
143 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
144 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
145 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
146 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
147 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
148 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
149 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
150 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|